Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewExternal funding in the biotechnology sector will help achieve strategic autonomy for Spai...
Strategic autonomy in the European healthcare sector can be supported in three areas: simplifying the European regulatory framework, reducing administrative burdens, and removing barriers to
-
Press releaseExternal funding in the biotechnology sector will help achieve strategic autonomy for Spai...
The majority of biotechnology companies are small and micro-enterprises that do not have products on the market and do not generate the necessary resources to finance their activities. There is an
-
NewThe biotechnology industry has become a key player in the fight against antimicrobial resi...
The sector has radically transformed the discovery of new drugs and therapeutic solutions. Worldwide, there are over 300 approved medications for approximately 250 indications and a thousand molecules
-
Press releaseThe biotechnology industry has become a key player in the fight against antimicrobial resi...
The sector has radically transformed the discovery of new drugs and therapeutic solutions. Worldwide, there are over 300 approved medications for approximately 250 indications and a thousand molecules
-
New#BIOSPAIN2023Interview | "In Spain, access to suitable financing can be a challenge, espec...
We spoke with Damià Tormo, General Partner & Co-founder of Columbus Venture Partners and Bronze Sponsor of BIOSPAIN 2023, about the challenges in the biotechnology sector.
-
New#BIOSPAIN2023 Interview | "Open Innovation Test Beds (OITBs) are inherently multinational ...
Ángel del Pozo, Deputy Manager of Programs Strategy at Biokeralty Research Institute and Scientific and Technical Manager of Safe-N-Medtech, discusses the current landscape of OITBs as a Bronze
-
NewBIOSPAIN 2023 brings together the global biotechnology industry in Barcelona
The inauguration ceremony featured the President of AseBio, Ana Polanco; the Secretary of State for Trade, Xiana Margarida Méndez; the Minister of Business and Labor of the Government of Catalonia
-
New#BIOSPAIN2023Interview | "Exploring space with robots and humans opens new frontiers and a...
We interview Sara García Alonso, Molecular Biologist & member of the Astronaut Reserve of the European Space Agency (ESA). She shares her experience as one of the keynote speakers at BIOSPAIN 2023.
-
New#BIOSPAIN2023 Interview | "The biotechnology sector in Spain presents a very dynamic lands...
José María Giménez Arnau, Chief Scientific & Medical Officer of ESTEVE, Gold Sponsor of BIOSPAIN 2023, discusses the state of the 'biotech' sector and shares the keys to the company's new innovation
-
New#BIOSPAIN2023Interview | "The biotechnology sector is in full expansion"
More than 100 investors will gather at BIOSPAIN 2023, an international benchmark event in the biotechnology sector. Among them is Wellington Partners. We talked to Arturo Urrios, Venture Advisor.
-
New#BIOSPAIN2023Interview | This is how Acelera Startups Sectorial Biotech works, the proposa...
Antonio López, CEO of SILO, a Bronze Sponsor of BIOSPAIN 2023, shares all the details about the Acelera Startups Sectorial Biotech program.
-
New#BIOSPAIN2023 Interview | "Entrepreneurial Activity in Spain is Lower, but More Resilient ...
We analyze Spain's entrepreneurial capacity under the brand Spain Up Nation, an initiative of the Government of Spain and Platinum Sponsor of BIOSPAIN 2023, with José Bayón, CEO.
-
New#BIOSPAIN2023Interview | We discover the first collaborative project between Alexion and A...
A space whose primary goal is to become one of the largest private centers of excellence in clinical development and innovation in Europe.
-
New#BIOSPAIN2023Interview | "There has been a growing trend in recent years in key indicators...
We are discussing the innovation ecosystem in Southern Europe in the biotechnology sector with Jose Terencio, Vice President Grifols Innovation and New Technologies (GIANT), Platinum Sponsor of
-
New#BIOSPAIN2023Interview | "At Amgen, we harness the full potential of biology and technolog...
The combination of genetics and biotechnology is laying the groundwork for the future of medicine. This horizon is being discussed with Miquel Balcells, the Medical Director of Amgen.
-
New#BIOSPAIN2023 Interview | "Spain has become a global benchmark in clinical trials in recen...
Amelia Martín Uranga, Director of Clinical and Translational Research at Farmaindustria - Innovative Medicines, Bronze Sponsor of BIOSPAIN, discusses the barriers between basic research and the
-
NewAseBio analyzes the use and barriers of digital tools in the Drug Discovery process
The Drug Discovery Working Group of AseBio has developed the document "New Technologies in the Drug Discovery Process," addressing trends and barriers in the biotech sector regarding the use of
-
New#BIOSPAIN2023Interview | "Genome editing has the potential to address real challenges for ...
We talked to with Richard Borreani, Public Affairs, Science & Sustainability Iberia at Bayer, the Gold Sponsor of BIOSPAIN 2023, about new genomic techniques and the challenge of their regulation in
-
NewCEISA participates in the IX edition of Farmaforum
On 20 and 21 September, CEISA will be present at Farmaforum, one of the most important events in the pharmaceutical sector in Spain.
-
New#BIOSPAIN2023Interview | "The quality of the Spanish healthcare system ensures a perfect k...
We analyze the potential of artificial intelligence as one of the technologies poised to revolutionize healthcare, with Owkin, Bronze Sponsor of BIOSPAIN 2023.
-
New#BIOSPAIN2023Interview | "Regulatory agencies are aware of the need for new standards in t...
Oriol Penon, Director of Strategy and Innovation at Asphalion, Silver Sponsor of BIOSPAIN 2023, analyzes the main regulatory barriers in accessing innovative medications.